UBS Maintains Neutral on Astera Labs, Raises Price Target to $400

Benzinga Newsdesk www.benzinga.com Neutral 50.0%

Neg 0% Neu 50% Pos 0%

UBS analyst Natalia Winkler maintains Astera Labs (NASDAQ:ALAB) with a Neutral and raises the price target from $205 to $400.